Ticker Information
Ticker
ZTSCompany Name
ZOETIS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NYSE6.02%Capital Expenditures Margin
VS
Market
31
Sector
26
Industry
7
History
68
$ 77.51Close
$ 71.86 - $ 156.7652-Week Range
ZOETIS INC - Capital Expenditures Margin Chart Analysis (TTM)
Date Range
Zoom
ZTS - Capital Expenditures Margin Historical Data
| Date | Capital Expenditure | Revenues | Capital Expenditures Margin |
|---|---|---|---|
| 2026-03-31 | $ 572M | $ 9.51B | 6.02% |
| 2025-12-31 | $ 621M | $ 9.47B | 6.56% |
| 2025-09-30 | $ 675M | $ 9.4B | 7.18% |
| 2025-06-30 | $ 710M | $ 9.38B | 7.57% |
| 2025-03-31 | $ 664M | $ 9.29B | 7.15% |
| 2024-12-31 | $ 654M | $ 9.26B | 7.07% |
| 2024-09-30 | $ 636M | $ 9.15B | 6.95% |
| 2024-06-30 | $ 613M | $ 8.91B | 6.88% |
| 2024-03-31 | $ 646M | $ 8.73B | 7.4% |
| 2023-12-31 | $ 728M | $ 8.54B | 8.52% |
Key Performance Insights, Last 5 Years
- ✓ ZOETIS INC's latest trailing twelve months (TTM) CapEx % stands at 6.02%.
- ✓ Over the past 5 years, ZOETIS INC's average CapEx % has been 7.15%.
- ✓ The median CapEx % for ZOETIS INC during this period was 7.11%
- ✓ ZOETIS INC reached its highest CapEx % over the past 5 years at 8.64%.
- ✓ The lowest CapEx % recorded by ZOETIS INC in the same timeframe 6.02%
ZOETIS INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
| Company | CapEx % |
|---|---|
| BIIB : BIOGEN INC | 1.91% |
| A : AGILENT TECHNOLOGIES INC | 5.05% |
| TEVA : TEVA PHARMACEUTICAL INDUSTRIES LTD | 3.12% |
| VTRS : VIATRIS INC | 2.41% |
| ONC : BEONE MEDICINES LTD | 2.97% |
| BHC : BAUSCH HEALTH COMPANIES INC | 4.08% |
| ELAN : ELANCO ANIMAL HEALTH INC | 5.35% |
| DGX : QUEST DIAGNOSTICS INC | 4.79% |
| RMD : RESMED INC | 2.45% |
| EW : EDWARDS LIFESCIENCES CORP | 4.27% |
Similar metrics to CapEx %:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %CapEx % for ZOETIS INC is calculated as follows:
CapEx [ $ 572M ] / Revenues [ $ 9.51B ]
(=) CapEx % [ 6.02% ] ZTS - Capital Expenditures Margin, Last 5 years
6.02%
Minimum
Mar 31, 2026
8.64%
Maximum
Jun 30, 2023
7.15%
Average
7.11%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.39% with a standard deviation of 3.24%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.8K |
|---|---|
| min | 0% |
| max | 14.83% |
| average | 3.39% |
| median | 2.42% |
| std | 3.24% |